歐派家居(603833.SH)董事譚欽興擬減持合計不超20萬股
格隆匯1月3日丨歐派家居(603833.SH)公佈,公司董事譚欽興合計持有公司股份118.17哇股(其中:IPO前取得的股份為112.53萬股;因公司2017年限制性股票激勵計劃獲授的限制性股票5.64萬股),佔公司當前總股本的0.2812%。
因個人財務需求,董事譚欽興擬自2020年2月3日起至2020年7月31日期間內,通過集中競價等方式減持其所持公司無限售條件流通股不超過20萬股(含),佔公司當前總股本的0.0476%,佔其持有的無限售條件流通股總數的16.9248%,減持價格按市場價格確定,且不低於發行價格。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.